Effects of Panax notoginseng saponins on mRNA expressions of interleukin-1β, its correlative factors and cysteinyl-aspartate specific protease after cerebral ischemia-reperfusion in rats

Journal of Chinese Integrative Medicine

Volumn 5, Issue 3, 2007, Pages 328-332

  Tang, Ying Hong ^a   Zhang, Shu Ping ^a   Liang, Yan ^a   Deng, Chang Qing ^a  

^a HUNAN UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Brain ischemia; Caspase; Interleukin 1; Interleukin 1 ; Rats; Receptor; Reperfusion; Reverse transcription polymerase chain reaction

Indexed keywords

CASPASE; CASPASE 3; CASPASE 8; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MESSENGER RNA; NYLON; PANAX NOTOGINSENG EXTRACT; SAPONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; GENE EXPRESSION; GINSENG; INTERNAL CAROTID ARTERY; NONHUMAN; RAT; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 34249655007     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jcim20070319     Document Type: Article

References (13)

1. Stanimirovic D, Satoh K. Inflammatory mediators of cerebral endothelium: a role in ischemic brain inflammation. Brain Pathol. 2000; 10(1): 113-126.
2. Charriaut-Marlangue C, Margaill I, Represa A, et al. Apoptosis and necrosis after reversible focal ischemia: an in situ DNA fragmentation analysis. J Cereb Blood Flow Metab. 1996; 16(2): 186-194.
3. Pettmann B, Henderson CE. Neuronal cell death. Neuron. 1998; 20(4): 633-647.
4. Liu JH, Ji FY, Wang T, et al. Protective effects of Panax notoginseng saponins on cerebral ischemia-reperfusion injury in rats. Zhongguo Lin Chuang Shen Jing Ke Xue. 2002; 10(1): 90. Chinese.
5. He W, Zhu ZP, Liu JX, et al. Study on therapeutic window of opportunity for Panax notoginseng saponins following focal cerebral ischemia/reperfusion injury in rats. Zhong Yao Cai. 2004; 27(1): 25-27. Chinese with abstract in English.
6. Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989; 20(1): 84-91.
7. Basu A, Lazovic J, Krady JK, et al. Interleukin-1 and the interleukin-1 type 1 receptor are essential for the progressive neurodegeneration that ensues subsequent to a mild hypoxic/ischemic injury. J Cereb Blood Flow Metab. 2005; 25(1): 17-29.
8. Sharma BK, Kumar K. Role of proinflarnmatory cytokines in cerebral ischemia: a review. Metab Brain Dis. 1998; 13(1): 1-8.
9. Basu A, Krady JK, Omalley M, et al. The type 1 interleukin-1 receptor is essential for the efficient activation of microglia and the induction of multiple proinflarnmatory mediators in response to brain injury. J Neurosci. 2002; 22(14): 6071-6082.
10. Wang X, Barone FC, Aiyar NV, et al. Interleukin-1 receptor and receptor antagonist gene expression after focal stroke in rats. Stroke. 1997; 28(1): 155-161.
11. Rothlein R. Overview of leukocyte adhesion. Neurology. 1997; 49(5 suppl 4): S3-S4.
12. Srinivasula SM, Fernandes-Alnemri T, Zangrilli J, et al. The Ced-3/ interleukin 1beta converting enzyme-like homolog Mch6 and the lamin-cleaving enzyme Mch2alpha are substrates for the apoptotic mediator CPP32. J Biol Chem. 1996; 271(43): 27099-27106.
13. Matsushita K, Wu Y, Qiu J, et al. Fas receptor and neuronal cell death after spinal cord ischemia. J Neurosci. 2000; 20(18): 6879-6887.